X inactivation and Barr bodies influence the phenotypic presentation of Turner syndrome variants.
Is it true that X inactivation and Barr bodies influence the phenotypic presentation of Turner syndrome variants?
Yes. Evidence from genetic and clinical studies supports the premise that X chromosome dosage, inactivation patterns, and heterochromatin formation (Barr bodies) play a substantial role in shaping the phenotypic variations observed in Turner syndrome and related conditions.
Verdict: SUPPORTED · 3 sources for, 0 against · Last checked
The retrieved literature extensively covers how X chromosome dosage anomalies, X-inactivation mechanics, and heterochromatin dosage (Barr bodies) directly impact phenotypic differences and disease risks, including Turner syndrome presentations and mosaicism. Papers 3, 5, and 11 provide direct or closely related mechanistic backing for the claim, and no papers refute it.
Get citation
AA, V., I, A., J, I., P, C., & ST, d. R. (2024). Female-bias in systemic lupus erythematosus: How much is the X chromosome to blame?. doi.org. https://doi.org/10.1186/s13293-024-00650-y
See more details
Get citation
M, C. & KH, M. (2022). Satellite DNAs and human sex chromosome variation.. doi.org. https://doi.org/10.1016/j.semcdb.2022.04.022
Get citation
Vaidya, P. & Vaidya, A. (2023). Turner Syndrome with Mosaicism of X Chromosome: A Case Report. doi.org. https://doi.org/10.31729/jnma.8168
Receipt History
Challenge the receipt
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
Terms · Privacy · How verdicts work